Hutch News

Hutch News

Stories tagged 'CMV'

Adam Geballe elected AAAS Fellow

Hutch virologist honored for revealing key players in molecular ‘arms race’ between viruses and hosts

Nov. 20, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Adam Geballe elected AAAS Fellow for pinpointing key players in molecular 'arms race' between viruses and human hosts

View story >

Good News at Fred Hutch

Celebrating faculty and staff achievements

March 3, 2016

Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care; Hutch study finds CMV viral load can act as surrogate endpoint for clinical trials; A new target for Tumor Paint: BLZ-100 lights up head and neck cancers; Dr. Stephen Tapscott appointed to NIAMS advisory council

View story >

New vaccine may prevent cytomegalovirus infection

Vaccine and Infectious Disease Institute researchers co-author study on vaccine with potential to prevent the most common virus transmitted by a pregnant woman to her unborn child

March 23, 2009

A new vaccine that has the potential to be the first to prevent maternal and congenital cytomegalovirus (CMV) infection was detailed in a study published in the March 19 edition of the New England Journal of Medicine. Dr. Larry Corey, co-director of the Hutchinson Center’s Vaccine and Infectious Disease Institute, and Dr. Meei-li Huang, of VIDI and a research scientist in the Virology Division at the University of Washington and an affiliate member in VIDI, were co-authors of the paper with colleagues at the University of Alabama at Birmingham, who led the study.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.